NEW YORK (GenomeWeb) – Certest, a diagnostics developer and manufacturer based in Zaragoza, Spain, has been expanding operations to meet the growing demand for its molecular biology products.

Founded in 2002 as an immunodiagnostics firm, Certest specializes in CE-marked in vitro assays for clinical diagnosis that now include real-time PCR-based kits for detecting infectious diseases sold under the brand name ViaSure.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.